Sheng-yu Wang*, Wei Wu, Xuan Ma. Recurrent Seizures Manifestations in a Case of Congenital Hypoparathyroidism: a Case Report[J].Chinese Medical Sciences Journal, 2013, 28(4): 242-244.
Potts JT. Diseases of the parathyroid glandother hyperhypocalcemic disorders. In: Fauci AS, Braunwald E, Kasper DL, et al, editors. Harrison's principles of internal medicine. 17th ed. New York: McGraw Hills; 2008. p. 2377-96.
2
Shoback D. Clinical practice.Hypoparathyroidism. N Engl J Med 2008; 359: 391-403.
3
Tong GM, Rude RK. Magnesium deficiency in critical illness. J Intensive Care Med 2005; 20: 3-17.
4
Castilla-Guerra L, del Carmen Fernández-Moreno M, López-Chozas JM, et al. Electrolytes disturbances and seizures. Epilepsia 2006; 47: 1990-8.
5
Fulop M, Zeifer B. Case report: Extensive brain calcification in hypoparathyroidism. Am J Med Sci 1991; 302: 292-5.
6
Verulashvili IV, Glonti LSH, Miminoshvili DK, et al. Basal ganglia calcification: Clinical manifestations and diagnostic evaluation. Georgian Med News 2006; 140: 39-43.
7
Winer KK, Yanovski JA, Cutler GB Jr. Synthetic human parathyroid hormone 1-34 vs. calcitriol and calcium in the treatment of hypoparathyroidism: Results of a randomized crossover trial. JAMA 1996; 276: 631-6.
8
Winer KK, Zhang B, Shrader J, et al. Synthetic human parathyroid hormone 1-34 replacement therapy: A randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J Clin Endocrinol Metab 2012; 97: 391-9.
9
Winer KK, Ko CW, Reynolds JC, et al. Long-term treatment of hypoparathyroidism: A randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 2003; 88: 4214-20.